LIVESURE AMPHETAMINE SCREEN TEST— 510(k) K011609

Name: FDA 510(k) clearance K011609
Creator: U.S. Food and Drug Administration
Published: 2001-06-08

Substantially Equivalent

Pan Probe Biotech, Inc.

FDA 510(k) clearance K011609 for LIVESURE AMPHETAMINE SCREEN TEST, Substantially Equivalent on 2001-06-08. Applicant: Pan Probe Biotech, Inc.. Device class: 2.

Clearance details

Applicant: Pan Probe Biotech, Inc.
Product code: Code DKZ
Device class: Class 2
Regulation: 21 CFR 862.3100
Advisory panel: Clinical Toxicology
Date received: 2001-05-25
Decision date: 2001-06-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DKZ

view all

K240670 — DRI Ecstasy Plus Assay2024-10-30
K233019 — AllTest Multi-Drug Rapid Test Cup +3 more2023-12-13
K231137 — Xenta Drug Screen Cup, Xenta Drug Screen Dipcard2023-05-19
K200363 — Quidel Triage® TOX Drug Screen, 946002020-03-11
K191099 — Atlas Multi-Drugs Screening Test Cup, Atlas Multi-Drugs Screening Test Panel2019-10-03

More clearances from Pan Probe Biotech, Inc.

view all

K020968 — LIVESURE HCG URINARY PREGNANCY TEST STRIP AND TEST CARD2002-07-15
K013796 — LIVESURE METHADONE SCREEN TESTS2001-11-26
K012107 — LIVESURE PHENECYCLINE (PCP) SCREEN TESTS2001-07-20
K012131 — LIVESURE BENZODIAZEPINES SCREEN TESTS2001-07-20
K012133 — LIVESURE BARBITURATES SCREEN TEST2001-07-20

Data sourced from openFDA. This site is unofficial and independent of the FDA.